Skip to main content
TipRanks
Go Ultimate75% OFF

AstraZeneca Pharma India Limited (ASTRAZEN) Stock Statistics & Valuation Metrics

44 Followers

Total Valuation

AstraZeneca Pharma India Limited has a market cap or net worth of INR 154.16B. The enterprise value is INR 149.93B.

Market Cap
INR 154.16B
Enterprise Value
INR 149.93B

Share Statistics

AstraZeneca Pharma India Limited has 25,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
25,000,000
Owned by Insiders
―
Owned by Institutions
2.60%

Financial Efficiency

AstraZeneca Pharma India Limited’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.00%.

Return on Equity (ROE)
0.21
Return on Assets (ROA)
0.09
Return on Invested Capital (ROIC)
17.00%
Return on Capital Employed (ROCE)
0.23
Revenue Per Employee
29.94M
Profits Per Employee
2.47M
Employee Count
760
Asset Turnover
1.14
Inventory Turnover
1.63

Valuation Ratios

The current PE Ratio of AstraZeneca Pharma India Limited is 86.76. AstraZeneca Pharma India Limited’s PEG ratio is -8.06.

PE Ratio
86.76
PS Ratio
5.93
PB Ratio
17.55
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
-8.06

Income Statement

In the last 12 months, AstraZeneca Pharma India Limited had revenue of 22.76B and earned 1.88B in profits. Earnings per share was 75.01.

Revenue
22.76B
Gross Profit
6.02B
Operating Income
2.33B
Pretax Income
2.52B
Net Income
1.88B
EBITDA
2.85B
Earnings Per Share (EPS)
75.01

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

AstraZeneca Pharma India Limited pays an annual dividend of INR 32.00, resulting in a dividend yield of 0.58%

Dividend Per Share
INR 32.00
Dividend Yield
0.58%
Payout Ratio
40.17%
Free Cash Flow Yield
0.00%
Earnings Yield
1.15%

Stock Price Statistics

Beta
0.67
52-Week Price Change
-32.48%
50-Day Moving Average
6316.54
200-Day Moving Average
7759.93
Relative Strength Index (RSI)
45.79
Average Volume (3m)
545

Important Dates

AstraZeneca Pharma India Limited upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 14, 2027
Ex-Dividend Date
Jul 18, 2025

Financial Position

AstraZeneca Pharma India Limited as a current ratio of 1.77, with Debt / Equity ratio of 12.68%

Current Ratio
1.77
Quick Ratio
0.73
Debt to Market Cap
0.00
Net Debt to EBITDA
-1.18
Interest Coverage Ratio
51.99

Taxes

In the past 12 months, AstraZeneca Pharma India Limited has paid 646.80M in taxes.

Income Tax
646.80M
Effective Tax Rate
0.26

Enterprise Valuation

AstraZeneca Pharma India Limited EV to EBITDA ratio is 57.06, with an EV/FCF ratio of 0.00.

EV to Sales
5.74
EV to EBITDA
57.06
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

AstraZeneca Pharma India Limited has INR 5.87B in cash and marketable securities with INR 962.10M in debt, giving a net cash position of INR 4.90B billion.

Cash & Marketable Securities
INR 5.87B
Total Debt
INR 962.10M
Net Cash
INR 4.90B
Net Cash Per Share
INR 196.15
Tangible Book Value Per Share
INR 351.54

Margins

Gross margin is 30.16%, with operating margin of 8.85%, and net profit margin of 6.83%.

Gross Margin
30.16%
Operating Margin
8.85%
Pretax Margin
9.37%
Net Profit Margin
6.83%
EBITDA Margin
10.06%
EBIT Margin
9.30%

Analyst Forecast

The average price target for AstraZeneca Pharma India Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
29.70%
EPS Growth Forecast
-10.76%

Scores

Smart Score
―
AI Score
49